BridgeBio Pharma Inc.
BridgeBio Pharma Inc. (BBIO) — Form 10-Q: Quarterly report
About this filing
BridgeBio Pharma Inc. (BBIO) filed Form 10-Q (quarterly report) with the SEC on Oct 29, 2026. A 10-Q is the company’s quarterly financial report.
Key facts
- Document
- 10-Q
More BBIO filings
- SC 13G/A
Filed Nov 12, 2026
- 4
Filed Nov 3, 2026
- 8-K
Filed Oct 29, 2026
- SC 13G
Filed Oct 27, 2026
- 8-K
Filed Oct 13, 2026
- 4
Filed Sep 21, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.